Guidelines

54 entries

Speciality / institutional guidelines

Normal vital signs according to ageNormal vital signs according to age→
Notice 14 March 2025: Supply Constraints with Docetaxel 200mg/ml Injection 1ml for Oncology Treatment and Interim Therapeutic AlternativesThe Tertiary and Quaternary Essential Medicines List (EML) currently recommends the use of a taxanes (paclitaxel or docetaxel) for the management of various cancers including breast, prostate and lung. Docetaxel 20mg/ml, 1ml injection, which is on National Contract from Accord Healthcare (Pty) Ltd, is currently unavailable. The docetaxel 20mg injection, will only be available at the end of April→
Notice 23 April 2026: Publication of the NEMLC Approved Updates to the Primary Healthcare (PHC) and Adult Hospital Level (AHL) Chapters for the Standard Treatment Guidelines (STGs) and Essential Medicines List (EML): 2025 - 2029 Review CycleIn the document below, is a list of the recently published 2026 chapter updates to previous editions of the PHC and AHL STGs and EML. Updates to chapters and supporting technical documents (medicine reviews, costing reports, NEMLC reports, implementation slides for PHC level) for the 2025 - 2029 review cycle are uploaded onto the National Health Insurance (NHI) webpage following finalisation for→
Notifiable medical conditions - Referral flowchartNotifiable medical conditions - Referral flowchart→